
Loading
Loading
C221H342N46O68Metabolic Research
A multi-receptor peptide reference material in a 20 mg presentation, listed for in-vitro and analytical research applications. Molecular reference information is provided below.
Batch documentation
Available on request
Canada-wide shipping
Tracked delivery
Lyophilized
Cold-chain handling
Documentation
A Certificate of Analysis for this material is not published yet. Ask us for its current documentation status before ordering.
Request documentationFor laboratory research use only. Not for human or veterinary use. No dosing or administration guidance is provided.
In the research literature, retatrutide is characterized as a synthetic triple receptor agonist — engineered to act at the GLP-1, GIP, and glucagon (GCGR) receptors. These pathways are studied in metabolic research models in relation to glucose regulation, insulin signalling, and energy expenditure, which is why it is used as a reference tool in incretin and glucagon-receptor research. Supplied for laboratory research only; no therapeutic, efficacy, or human/veterinary-use claims are made.
Provided for research context only. This material is supplied for laboratory, analytical, and research use exclusively — not for human or veterinary use. No therapeutic, diagnostic, dosing, or efficacy claims are made or implied.
A multi-receptor peptide reference material in a 20 mg presentation, listed for in-vitro and analytical research applications. Molecular reference information is provided below.
Retatrutide 20 mg is listed within the metabolic research category as a research reference material. This entry provides general and molecular reference information. Batch-specific documentation is published only when verified records are available for a listed material.
No reviews yet. Be the first to review Retatrutide 20 mg.
Reviews are by invitation — we email a link once an order has been delivered.